Skip to main navigation Skip to search Skip to main content

Pyrogenic immunomodulators increase the level of prostaglandin E2 in the blood simultaneously with the onset of fever

  • Dino Rotondo*
  • , Habib T. Abul
  • , Anthony S. Milton
  • , Jillian Davidson
  • *Corresponding author for this work
  • Department of Pharmacology
  • University of Aberdeen

Research output: Contribution to journal › Article › peer-review

89 Scopus citations

Abstract

Blood prostaglandin E2 (PGE2) levels, estimated by radioimmunoassay, and body temperatures of conscious rabbits were measured simultaneously during fever in response to polyinosinic: polycytidylic acid, lipopolysaccharide and interleukin 1/endogenous pyrogen. The effects of the antipyretic agent ketoprofen on both parameters was also studied. Significant rises (in the order of 6- to 8-fold) in the PGE2 level were observed after injection of either of the three pyrogens and occured simultaneously with the rise in temperature. Ketoprofen given after the onset of fever in response to the pyrogens produced an immediate defervescence and a simultaneous decrease in plasma PGE2. Ketoprofen given before the pyrogens prevented any rise in either body temperature or plasma PGE2 level. When animals were subjected to an environmental temperature of 34°C a hyperthermia was observed without any change in the blood PGE2 level. These results suggest that an increase in the blood PGE2 level may contribute to the pathogenesis of fever.

Original languageEnglish
Pages (from-to)145-152
Number of pages8
JournalEuropean Journal of Pharmacology
Volume154
Issue number2
DOIs
StatePublished - 13 Sep 1988
Externally publishedYes

Keywords

  • Fever
  • Immunomodulators
  • Prostaglandin E (blood)

Fingerprint

Dive into the research topics of 'Pyrogenic immunomodulators increase the level of prostaglandin E2 in the blood simultaneously with the onset of fever'. Together they form a unique fingerprint.

Cite this